Pharmacokinetics and Modeling of Betamethasone Therapy in Threatened Preterm Birth

D
David Haas, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of this study is to evaluate the pharmacokinetic, pharmacodynamic, and pharmacogenetic parameters of betamethasone and determine the differences in responses and benefit in pregnancy.

Description

The purpose of this study is to evaluate the pharmacokinetic, pharmacodynamic, and pharmacogenetic parameters of betamethasone and determine the differences in responses and benefit in pregnancy.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    respiratory distress syndrome
  • Age: - 100 Years
  • Gender: All
Updated on 18 Apr 2024. Study ID: 1604640151

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center